Immune-Onc Therapeutics Stock

Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.

Sign up today and learn more about Immune-Onc Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Immune-Onc Therapeutics Stock

Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.

Funding History

September 2016$7.0M
September 2018$33.0M
August 2020$2.1M
March 2021$73.0M
January 2023$25.0M

Management

President and CEO

Charlene Liao

Chief Financial Officer

Christopher Whitmore

Co-founder

Guo Liang Yu

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo